Program areas at CaringKind
Patient and family services - Caringkind offers a helpline run by professional staff; individual and family counseling sessions with licensed social workers; a vast network of support groups; and a wanderer's safety program. These services improve the affected individual and their caregiver's quality of life and decreases the stressful impact of Alzheimer's and dementia. Social workers identify areas of need and provide assistance and psychosocial support through education about the Disease and symptom management, problem solving, planning for future needs, and linkages with resources, particularly during transitional or crisis situations.
Public policy - advocates for public policies aimed at advancing research toward better therapies, detection, methods of prevention and ultimately a cure, as well as for better care and resources, and health and long-term coverage to ensure high-quality cost-effective care for people with Alzheimer's Disease and their families. Policy activities also include collaborating with other organizations to improve quality care and raise awareness of key issues.
Public awareness and education - Alzheimer's is a progressive, degenerative, and ultimately fatal Disease. Too few americans understand the current and future economic impact of alzheimer's. Already more than 6.7 million americans are living with Alzheimer's and more than 11 million people are providing unpaid care and support. This massive group is in need of information and resources. Caringkind has invested in education campaigns and initiatives to increase knowledge about Alzheimer's Disease and awareness of the organization as the center of help and hope. Key messages include the importance of early detection, resources for people with Alzheimer's and their families, and the societal impact of the Disease. Millions of constituents are engaged to educate their communities and workplaces.
Research - Caringkind remains committed to the advancement of research towards the goal of eliminating Alzheimer's Disease. We achieve this goal through collaborating with research centers, and scientists in New York City, nationally and internationally; helping to recruit subjects for research, educting our community about the importance of research, and how to participate in research trials. All restricted pharmacological research donations are passed-through to our research partners.